Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Nephrol Dial Transplant
Prif Awduron: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2016
Pynciau:
CLINICAL SCIENCE
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://ncbi.nlm.nih.gov/pubmed/26429974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg